Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
about
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy.High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.Exemestane Use in Postmenopausal Women at High Risk for Invasive Breast Cancer: Evaluating Biomarkers of Efficacy and Safety.Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor TherapyPatient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.Mammographic density-a review on the current understanding of its association with breast cancer.Relationship Between Breast Density and Selective Estrogen-Receptor Modulators, Aromatase Inhibitors, Physical Activity, and Diet: A Systematic Review.The implications of genetic variation for the pharmacokinetics and pharmacodynamics of aromatase inhibitors.Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors.Institutional profile of pharmacogenetics within University of Michigan College of Pharmacy.Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors.Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.
P2860
Q34020925-97AEC2AF-6CFC-4C11-BFE3-4685C4830C68Q35797147-2B1ACE79-4B94-456F-9487-5E5F704266F6Q36446246-D5230EC7-14AE-43AE-B273-7AFA537578D8Q36649704-8096B7D1-A484-4C9E-B498-A0E147E0691CQ36693164-9FE9AA5E-E272-4A1B-AADA-CDFC4E85AAC6Q36884366-746CC797-933B-4F27-BCF3-BE38C54EB96DQ38194952-38EA614D-7D92-4B71-B708-6067FC3A5548Q38821494-472D3EA6-98BC-4784-9692-737B38425BFCQ38851505-654AE0E3-59B3-40D1-B121-42EE7276A3BEQ40440059-F0575AEA-C6CD-47BF-BF55-29953CEAAA87Q47312891-DA4810F1-109B-40D5-9EC0-76B53C3526DAQ47577378-DD97EA57-2821-4C84-8629-605CE6951F34Q47594270-2D62AC97-6023-40D7-82DC-9D26E76C4F35
P2860
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
@en
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
@nl
type
label
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
@en
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
@nl
prefLabel
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
@en
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects.
@nl
P2093
P2860
P50
P356
P1476
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects
@en
P2093
A M Storniolo
A T Nguyen
C P Goswami
D A Flockhart
M A Helvie
P2860
P2888
P304
P356
10.1038/BJC.2013.587
P407
P577
2013-10-01T00:00:00Z